RE:Christian talking at 4th Global Liver Congress The regulators are talking at this meeting too. Maybe something new???
It looks like a more holistic conference (science, industry, regulatory) than some of the others.
qwerty22 wrote:
https://www.global-engage.com/event/nash/
You can access the agenda by clicking on 'read the agenda'. (I registered with totally made-up details)
Here is the blurb on Christian's presentation.
CHRISTIAN MARSOLAIS
Senior Vice President and Chief Medical Officer, Theratechnologies, Canada
Treating NASH through a unique mode of action with tesamorelin
Tesamorelin is a Growth Hormone Releasing Hormone (GHRH) Analog indicated
for the treatment of visceral adipose tissue accumulation in People Living with HIV. Tesamorelin,with over 10 years of real-life data,has a well-established safety and efficacy profile.It has a significant impact on the accumulation of ectopic fat, reduction of visceral adipose tissue, reduction of fat accumulation inthe muscle (trunkmusclegroup) and decrease of liver fat accumulation while increasing lean body mass. Based on transcriptomic analysis of liver biopsies, tesamorelin was shown to have significant impact on oxidative phosphorylation, inflammatory makers related to fibrosis, and improvements in gene expression related to favorable hepatocellular carcinoma prognosis. Tesamorelin is currently being evaluated as an investigational treatment for all people living with nonalcoholic steatohepatitis (NASH).